Acknowledgement
본 연구는 한국연구재단 이공학개인기초기본연구의 지원사업 (NRF-2018R1D1A1B07050267) 및 한국연구재단의 4단계 두뇌한국21 사업(4단계 BK21 사업)으로 지원된 연구이다(5199990614732).
References
- Albibi R, McCallum RW. Metoclopramide: Pharmacology and Clinical application. Ann Intern Med 1983;98(1):86-95. https://doi.org/10.7326/0003-4819-98-1-86
- Junqueira DR, Bennett D, Huh SY, Fahrbach K, Neupane B, Betts M. Risk of Adverse Events Associated with Domperidone and Metoclopramide in Gastroparesis: Systematic Review and Meta-analysis. Drugs R D 2023;23(1):1-20. https://doi.org/10.1007/s40268-023-00413-x
- European Medicines Agency. European Medicines Agency recommends changes to the use of metoclopramide. Available from: https://www.ema.europa.eu/en/news/european-medicines-agency-recommends-changes-use-metoclopramide. Accessed March 7, 2023.
- The Ministry of Food and Drug Administration. Pharmaceutical integrated information system. Available from: https://nedrug.mfds.go.kr/searchDrug. Accessed April 22, 2023.
- Drugwatch. Reglan & Tardive Dyskinesia. Available from: https://www.drugwatch.com/reglan/. Accessed June 22, 2023.
- U.S Food and Drug Administration. FDA online label repository. Available from: https://labels.fda.gov/. Accessed March 8, 2023.
- Micromedex. Micromedex system database. Available from: https://www.micromedexsolutions.com/home/dispatch. Accessed March 8, 2023.
- Baek J-W, Yang BR, Choi S, Shin K-H. Signal Detection for Adverse Events of Finasteride Using Korea Adverse Event Reporting System (KAERS) Database. KJCP 2021;31(4):324-31.
- Jang M-G, Gu H-J, Kim J, Shin K-H. Signal detection for adverse event of varenicline in Korea Adverse Event Reporting System. KJCP 2022;32(1):1-7.
- Miller LG, Jankovic J. Metoclopramide-induced movement disorders. Clinical findings with a review of the literature. Arch Intern Med 1989;149(11):2486-92.
- Yis U, Ozdemir D, Duman M, Unal N. Metoclopramide induced dystonia in children: two case reports. Eur J Emerg Med 2005;12(3):117-9. https://doi.org/10.1097/00063110-200506000-00004
- Moos DD, Hansen DJ. Metoclopramide and extrapyramidal symptoms: a case report. J Perianesth Nurs 2008;23(5):292-9. https://doi.org/10.1016/j.jopan.2008.07.006
- Mejia NI, Jankovic J. Metoclopramide-induced tardive dyskinesia in an infant. Mov Disord 2005;20(1):86-9. https://doi.org/10.1002/mds.20259
- Lang L. FDA Calls for Boxed Warning for Metoclopramide. Gastroenterology 2009;136:2039.
- Ehrenpreis ED, Deepak P, Sifuentes H, Devi R, Du H, Leikin JB. The Metoclopramide Black Box Warning for Tardive Dyskinesia: Effect on Clinical Practice, Adverse Event Reporting, and Prescription Drug Lawsuits. Am J Gastroenterol 2013;108(6):866-72. https://doi.org/10.1038/ajg.2012.300
- Surawski RJ, Quinn DK. Metoclopramide and Homicidal Ideation: A Case Report and Literature Review. Psychosomatics 2011;52(5):403-9. https://doi.org/10.1016/j.psym.2011.02.001
- Feldman EL, Callaghan BC, Pop-Busui R, et al. Diabetic neuropathy. Nat Rev Dis Primers 2019;5(1):42.
- Kim H, Suh HS. Effects of a Safety Letter on Metoclopramide Use in Korea: An Interrupted Time-Series Analysis. Risk Manag Healthc Policy 2020;13:1335-41. https://doi.org/10.2147/RMHP.S263579